Mesoblast

+$0.03 (+0.40%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mesoblast and other ETFs, options, and stocks.

About MESO

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases.

CEO
Silviu Itescu
Employees
102
Headquarters
Melbourne, Victoria (VIC)
Founded
2004

MESO Key Statistics

Market Cap
1.01B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
86.38K
High Today
$7.58
Low Today
$7.39
Open Price
$7.40
Volume
44.03K
52 Week High
$21.28
52 Week Low
$6.67

MESO Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Aug 25, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure